Industry News
Pharmaceutical Industry News
Teva Pharmaceutical is launching…
Teva Pharmaceutical is launching its first global innovation platform, challenging startups to submit novel strategies to tackle seven industry hurdles that run the gamut from manufacturing to R&D.
With a fresh FDA endorsement for…
With a fresh FDA endorsement for its drug plozasiran, Pasadena-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm.
The bankruptcy reorganization plan…
The bankruptcy reorganization plan will deliver $7.4 billion to creditors, including an up-to-$7 billion contribution from the Sackler family, while Purdue Pharma will dissolve into a new company called Knoa Pharma.
The distinction is important…
The distinction is important because under Avadel's existing transaction agreement with Alkermes, the latter company now has five business days to "discuss or negotiate in good faith" any potential amendments to its prior offer.
Positive results from a…
Positive results from a proof-of-concept study evaluating Merck’s Winrevair pave the way for further study of the activin signaling inhibitor as a potential treatment for a subset of heart failure patients.
Monday, the FDA’s Office of…
Monday, the FDA’s Office of Prescription Drug Promotion posted a new untitled letter dated Sept. 23 and addressed to AstraZeneca.
In a bid to deepen its…
In a bid to deepen its manufacturing foothold in the U.S., Regeneron Pharmaceuticals in April pledged production and infrastructure investments surpassing $7 billion across North Carolina and its native Empire State. Now, more than half
The company will spend…
The company will spend approximately $1.5 billion in capital investments to grow its U.S. plasma-based manufacturing capabilities over the next five years.
Having found success with its Jazz…
Having found success with its Jazz and BeOne-licensed cancer med Ziihera, Zymeworks will apply the commercial and late-stage framework for that drug to all its products going forward. The new licensing-focused model forms part of
Cytokinetics is following in the…
Cytokinetics is following in the footsteps of Bristol Myers Squibb as it prepares to try to wrest control of the heart disease market away from the Big Pharma. About a year after BMS backed an
Biogen has had two years to gear…
Biogen has had two years to gear up for the impending launch of Sandoz's biosimilar Tyruko, which has now hit the U.S. market after earning FDA approval in 2023.
Days after joining its fellow…
Days after joining its fellow GLP-1 giant, Eli Lilly, in coming to agreements with the Trump administration to slash the costs of their uber-popular weight loss meds in the U.S., Novo Nordisk has pulled back
Jazz described the readout as…
Jazz described the readout as boosting its confidence that it has a HER2-targeted "agent-of-choice" for first-line patients with HER2-positive gastroesophageal adenocarcinoma (GEA), including cancers of the stomach, gastroesophageal junction and esophagus.
Thanks to a new accord with the…
Thanks to a new accord with the United States, import tariffs on many key goods from Liechtenstein and Switzerland—including pharmaceuticals—will be capped at 15%, falling in line with the terms in an EU agreement the
A Pill for Women’s Libido Meets a Cultural Moment
A decade ago, Cindy Eckert struggled to convince skeptics about a drug for premenopausal women. Lately, her business is booming.
Trump Is Wrong About Fentanyl in Almost Every Way
Everything the Trump administration is doing to stop the flow of drugs is just making the problem worse.
F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths
A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.
The updated label now includes a…
The updated label now includes a boxed warning and a new “limitation of use" in addition to the removal of the prior indication for non-ambulatory patients with Duchenne muscular dystrophy.
Sharon Camp, Mother of the ‘Plan B’ Contraceptive Pill, Dies at 81
An advocate for women’s reproductive health, she started one of the world’s smallest pharmaceutical companies to bring an emergency birth-control method to market.
The European Medicines Agency’s…
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) cleared 10 products in total, including two biosimilars and two generics.